||**Sempervirens Foundation**<br>|**Sempervirens Foundation**<br>|**Sempervirens Foundation**<br>|**1187941**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|Period start date<br>1-Jan-23|**To**|Period end date<br>31-Dec-23||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**<br>Donation<br>**5,001**<br>Interest<br>**1**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**5,002**<br>**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total receipts_                   5,002**<br>**A3 Payments**<br>Governance costs - bank charges<br>**59**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                            59**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total payments_                        59**<br>**_Net of receipts/(payments)_                   4,943**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**872**<br>**_Cash funds this year end_                   5,815**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**5,001**<br>**1**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**5,002**<br>**-**<br>**-**<br>**-**<br>**5,002**<br>**59**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**59**<br>**-**<br>**-**<br>**-**<br>**59**<br>**4,943**<br>**-**<br>**872**<br>**5,815**|**Last year**<br>**to the nearest £**|
||||**-**|**5,001**|**-**|
||||**-**|**1**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**5,002**|**-**|
|||||||
||||**-**|**-**||
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
|||||||
||||**-**|**5,002**|**-**|
|||||||
||||**-**|**59**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**59**|**-**|
|||||||
||||**-**|**-**||
||||**-**|**-**||
||||**-**|**-**|**-**|
|||||||
||||**-**|**59**|**-**|
|||||||
|||**-**|**-**|**4,943**|**-**|
|||**-**|**-**|**-**|**-**|
|||**-**|**-**|**872**|**-**|
|||**-**|**-**|**5,815**|**-**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>Bank account<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>Frederic Pilkington<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**5,814**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**5,814**<br>**-**<br>Agreement Error<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Frederic Pilkington<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||Frederic Pilkington|Frederic Pilkington|10/11/2024|
|||||



